Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip. (Q46595277)

23 December 2017

title

Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip. (English)

1 reference

23 December 2017

1 reference

1 reference

J Svartberg

1 reference

23 December 2017

I Agledahl

1 reference

23 December 2017

Y Figenschau

1 reference

23 December 2017

T Sildnes

1 reference

23 December 2017

K Waterloo

1 reference

23 December 2017

R Jorde

1 reference

23 December 2017

publication date

15 May 2008

1 reference

23 December 2017

International Journal of Impotence Research

published in

1 reference

23 December 2017

volume

1 reference

23 December 2017

issue

1 reference

23 December 2017

page(s)

378-387

1 reference

23 December 2017

The associations of age, lifestyle factors and chronic disease with testosterone in men: the Tromsø Study.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

Time for (more research on) testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

Association between heart rate and atherogenic blood lipid fractions in a population. The Tromsø Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromsø study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

Inflammatory markers in women with a recent history of gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

Development of the WHOQOL-old module.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

A critical evaluation of simple methods for the estimation of free testosterone in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

Effect of testosterone treatment on bone mineral density in men over 65 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

Effect of Testosterone and Estradiol in a Man with Aromatase Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

Effects of transdermal testosterone on cognitive function and health perception in older men with low bioavailable testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

Effect of Weight Loss with Reduction of Intra-Abdominal Fat on Lipid Metabolism in Older Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

Age, Disease, and Changing Sex Hormone Levels in Middle-Aged Men: Results of the Massachusetts Male Aging Study*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

7 January 2021

A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

7 January 2021

Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

7 January 2021

The effect of testosterone on health-related quality of life in elderly males - a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

7 January 2021

Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1038%2FIJIR.2008.19

7 January 2021

Identifiers

DOI

10.1038/IJIR.2008.19

1 reference

23 December 2017

Dimensions Publication ID

1017948272

0 references

1 reference

23 December 2017